Our Pricing

Cheapest Mounjaro Online UK - From £124.99 First Order

Published on: June 03, 2026

Finding the cheapest Mounjaro UK online pharmacy doesn't mean compromising on quality or safety. At Cured Pharmacy, you'll access genuine UK-licensed Mounjaro (tirzepatide) pens from £124.99, with transparent upfront pricing, free clinical consultation by UK prescribers, and 100% discreet delivery. Every prescription is dispensed by our GPhC-registered pharmacy team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensuring you receive authentic MHRA-approved medication at the lowest guaranteed UK price.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for chronic weight management [1]. Unlike older single-pathway treatments such as semaglutide or liraglutide, tirzepatide activates two natural incretin hormones that regulate blood sugar, slow gastric emptying, and reduce appetite through complementary mechanisms. This dual action produces significantly greater weight reduction in clinical trials compared to GLP-1-only medications.

In the landmark SURPASS-3 trial, patients receiving the 15mg Mounjaro dose achieved an average 22.5% body weight reduction over 72 weeks [1]. The SURMOUNT-1 trial demonstrated that adults with obesity (but without diabetes) lost an average of 20.9% of their body weight on the highest dose, with some participants losing up to 24% [2]. These results represent the most substantial weight loss outcomes seen with any approved medication to date, though individual results vary and depend on adherence to lifestyle modifications alongside treatment.

Mounjaro Price UK: Understanding the Cost

At Cured Pharmacy, Mounjaro starts from £124.99 per prescription, making us the cheapest Mounjaro UK online pharmacy with transparent pricing shown before you complete your consultation. Unlike some providers who hide costs until after assessment, we believe in complete price transparency. Your final cost depends on the dose your UK prescriber determines is clinically appropriate based on your medical history, current weight, and treatment goals.

Mounjaro is available in five dose strengths (2.5mg, 5mg, 7.5mg, 10mg, and 15mg), with treatment typically starting at the lowest dose and gradually increasing over 16-20 weeks to minimise gastrointestinal side effects [3]. Each KwikPen contains four weekly doses, meaning one pen lasts one month. Our pricing structure reflects the genuine UK-licensed product dispensed from our GPhC-registered pharmacy, not grey-market alternatives or compounded versions that lack MHRA approval.

We guarantee the lowest prices in the UK market. If you find a cheaper price for genuine Mounjaro from another UK-registered pharmacy, we'll match it. This commitment ensures you're accessing affordable weight management treatment without sacrificing safety, quality, or regulatory compliance.

What's Included in Your Mounjaro Prescription

Your Mounjaro prescription from Cured Pharmacy includes free clinical consultation (completed online in under 3 minutes), prescriber review by a UK-registered doctor or independent prescriber, dispensing by our GPhC-registered pharmacy team, discreet packaging with no external branding, and tracked delivery to your preferred UK address. There are no hidden consultation fees, membership charges, or subscription commitments unless you choose our optional repeat prescription service for added convenience.

Mounjaro vs Wegovy: Comparing Weight Loss Injections

Both Mounjaro and Wegovy are once-weekly injectable medications licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities. However, they work through different mechanisms and produce different clinical outcomes. Wegovy contains semaglutide, a GLP-1 receptor agonist that activates one incretin pathway, whilst Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors simultaneously [1][4].

Head-to-head trials show tirzepatide produces greater average weight loss than semaglutide. In the SURPASS-2 trial, participants on 15mg tirzepatide lost an average of 12.4kg compared to 6.2kg with 1mg semaglutide over 40 weeks [5]. The enhanced efficacy comes from the dual receptor activation, which amplifies appetite suppression and metabolic effects. However, both medications require subcutaneous injection, carry similar side effect profiles (predominantly gastrointestinal), and necessitate clinical monitoring.

Your choice between Mounjaro and Wegovy depends on individual factors including your weight loss goals, medical history, tolerance to side effects, and budget considerations. Wegovy starts from a lower price point, which may suit those beginning their weight management journey or with more modest targets. Mounjaro's superior efficacy data makes it appropriate for patients seeking maximum weight reduction, subject to prescriber approval.

Choosing Between Injectable and Oral Weight Loss Treatments

Injectable treatments like Mounjaro and Wegovy produce significantly greater weight loss than oral medications such as Orlistat or Mysimba, but they require weekly self-injection and come at higher cost. Oral options may be more suitable for patients uncomfortable with needles, those with lower BMI thresholds, or individuals seeking a trial treatment before progressing to injectables. Your UK prescriber will discuss all licensed options during your consultation to identify the most appropriate treatment for your circumstances.

How to Buy Mounjaro Online UK Safely

Mounjaro is a prescription-only medication in the UK, meaning it cannot legally be purchased without clinical assessment by a UK-registered prescriber. Any website offering to sell Mounjaro without a prescription is operating illegally and likely supplying counterfeit, expired, or improperly stored medication that poses serious health risks. At Cured Pharmacy, every Mounjaro prescription follows strict regulatory protocols to ensure patient safety and medication authenticity.

To buy Mounjaro online UK through our pharmacy, you'll complete a free online consultation that takes under 3 minutes. This clinical questionnaire collects essential medical information including your weight, height, existing health conditions, current medications, and previous weight loss attempts. A UK-registered doctor or independent prescriber reviews your submission within 24 hours and determines whether Mounjaro is clinically appropriate and safe for you. If approved, we dispense your prescription from our GPhC-registered pharmacy (registration number 9012511) and arrange discreet delivery to your UK address.

We source all Mounjaro stock directly from licensed UK wholesalers, ensuring every pen is genuine, MHRA-approved, and stored within the required 2-8°C temperature range throughout the supply chain. Your medication arrives with full patient information leaflets, disposal guidance for used pens, and access to our pharmacist support line for any questions during treatment. This comprehensive approach guarantees you receive the same standard of care as a traditional high-street pharmacy, with the added convenience of online access and competitive pricing.

Mounjaro Dosing and Treatment Timeline

Mounjaro treatment follows a structured dose escalation schedule designed to minimise side effects whilst optimising weight loss outcomes. All patients start with the 2.5mg dose for the first four weeks, regardless of their target maintenance dose [3]. This initial period allows your body to adapt to the medication's effects on gastric emptying and appetite regulation, significantly reducing the likelihood of severe nausea or vomiting.

After the first month, your prescriber will increase your dose to 5mg for four weeks, then 7.5mg, 10mg, and potentially 15mg at four-week intervals, depending on your tolerance and weight loss progress. The SURMOUNT-1 trial used this same escalation protocol, which proved effective in achieving the published weight loss outcomes whilst maintaining acceptable side effect profiles [2]. Most patients reach their maintenance dose between 16-20 weeks after starting treatment.

Clinical trials demonstrate that weight loss continues throughout the first 60-72 weeks of treatment, with the greatest reduction occurring during the dose escalation phase and early maintenance period [1][2]. Your UK prescriber will schedule regular reviews (typically every 12 weeks) to monitor your progress, assess for side effects, and determine whether to continue treatment. NICE guidance recommends discontinuing Mounjaro if patients have not achieved at least 5% weight loss after 6 months at the maximum tolerated dose, as continued use is unlikely to produce clinically meaningful benefits.

What to Expect During Your First Month

During your first four weeks on the 2.5mg starter dose, you may notice reduced appetite, earlier feelings of fullness during meals, and decreased food cravings. Some patients experience mild nausea, particularly in the first few days after each injection, though this typically diminishes as your body adjusts. Weight loss during the starter month is usually modest (1-3kg on average), as the primary purpose of this phase is physiological adaptation rather than maximum efficacy. Staying well-hydrated, eating smaller portions, and avoiding high-fat meals can help minimise gastrointestinal side effects.

Mounjaro Side Effects and Safety Considerations

The most common side effects of Mounjaro are gastrointestinal, affecting more than 10% of patients in clinical trials. These include nausea (reported by up to 30% of participants), diarrhoea, vomiting, constipation, abdominal pain, and reduced appetite [1][3]. These effects are typically mild to moderate in severity, occur most frequently after dose increases, and tend to diminish over several weeks as your body adapts to the medication. The gradual dose escalation protocol significantly reduces the intensity of these symptoms compared to starting at higher doses.

Less common but more serious side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, hypoglycaemia when used with other diabetes medications, kidney problems from dehydration, and changes in vision. Mounjaro carries a boxed warning in the US regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3]. As a precautionary measure, Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Your UK prescriber will review your complete medical history during consultation to identify any contraindications or conditions requiring additional monitoring. You should not use Mounjaro if you're pregnant, planning pregnancy, or breastfeeding, as weight loss during pregnancy poses risks to foetal development and tirzepatide's effects on pregnancy outcomes have not been adequately studied. If you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or allergic reactions, stop using Mounjaro immediately and seek medical attention. Our pharmacy team remains available throughout your treatment to address any concerns or unexpected symptoms.

Drug Interactions and Contraindications

Mounjaro slows gastric emptying, which can affect the absorption of oral medications, particularly those requiring rapid absorption or narrow therapeutic windows. If you take oral contraceptives, your prescriber may recommend switching to non-oral contraception or using barrier methods during the first four weeks after starting Mounjaro or increasing doses. Tirzepatide may increase the risk of hypoglycaemia when used alongside insulin or sulfonylureas, requiring dose adjustments of these medications. Always inform your prescriber of all medications, supplements, and herbal products you're currently taking during your consultation.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., Mao, H., Zhang, S., Ahmad, N. N., Bunck, M. C., & Benabbad, I. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/14298/smpc [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment alongside appropriate diet and exercise modifications.